Search

You searched for "digital"

1379 results found

Bilateral eye pain after contact lens wear: an inadvertent case of chemical eye injury

1 December 2022 | | EYE - General
Introduction There are around 4.1 million contact lens wearers in the UK [1]. While the vast majority of them do not experience any complications, over the past years there have been cases of acanthamoeba keratitis and multiple retained contact lenses...

Deciphering dark retinal patches

3 October 2024 | | EYE - Vitreo-Retinal
We present a case of bilateral extensive dark without pressure (DWP) located outside the retinal vascular arcades in a young female. This retinal finding is benign but, in some instances, darkened retinal patches could be associated with potential sight-threatening conditions....

Presumed DALK stromal graft rejection following Covid-19 infection

4 December 2024 | | EYE - Cornea
Case report A 45-year-old healthy male patient with a past ocular history of keratoconus and right deep-anterior lamellar keratoplasty (DALK) graft performed 10 months prior, presented to our eye casualty clinic with a two-day history of right photophobia and epiphora....

Zeiss Forum

1 December 2016 | | EYE - Imaging
The tech column this issue reports on the features and experience of using the Zeiss Forum software. I have overseen the installation, troubleshooting, training and use of the software over the last two years. As both a consultant specialising in...

Interview with Clinical Director of OpenEyes

1 April 2015 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Professor James Morgan is an Ophthalmic Consultant at Cardiff Hospital and also the clinical director of the OpenEyes programme. Given the national push for electronic records we felt hearing directly from James would be of interest. The interview was conducted...

ARx - Augmented Reality Headset

2 August 2022 | | EYE - General
In a continuing look at wearable technology, for those with sight impairment, for Aug/Sep we are looking at the recently released ARx. In previous issues we have covered the Envision Glasses and the OrCam MyEye. The ARx is a device...

The approach to angle-closure glaucoma

1 October 2016 | | EYE - Glaucoma
Further to my last article in Eye News (print issue) describing the diagnostic approaches to various clinical scenarios in glaucoma, the approach to angle-closure glaucoma (ACG), a situation terrifying for patient and registrar alike, will be discussed. Please refer to...

“Herr Doktor, I can’t see but I am driving”

1 February 2018 | | EYE - Vitreo-Retinal, EYE - General
This 56-year-old lady was quite puzzling. With her own glasses and the pinhole she merely managed to see the 1.3 and 1.0 logMAR lines with her right and left eye, respectively (I am currently working in Germany again, so goodbye...

A closed angle seldom comes alone

1 June 2017 | | EYE - Glaucoma
Case report An 89-year-old lady with dementia was referred to me out of hours by her GP with a few days history of an angry looking left eye for suspected elevated intraocular pressure (IOP). I discovered that this lady first...

Simulation in ophthalmology: a pedagogic viewpoint

1 April 2017 | | EYE - Cataract, EYE - Refractive
The advent of simulation technology has enhanced modern medical training. The first utilisation of simulation was in 1929 where Edward Link used this concept to develop a mechanical flight simulator [1]. Industries such as aviation, nuclear power and the military...

A log in the eye

1 February 2017 | | EYE - Vitreo-Retinal
"My friend wanted to show how far he could throw that log. So, he helicoptered it over his head, faster and faster and when he let go, it hit my eye at full speed,” a young lady of 19 years...

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

1 February 2017 | | EYE - Vitreo-Retinal
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...